Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Canaccord buying lots at 18 .

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Apr 11, 2024 2:28pm

275 Views

Post# 35983893

RE:RE:Canaccord buying lots at 18 .

Like I've said a few times this week. The share turnover is odd and I don't have any explanation. Usually when there is a massive block sitting on the ask at 0.18, it sends a message to not bid up the price but in this case it has been fine for trading.

Venture exchange shenanigans that we will never know the details?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec